Taken together, these data suggests that DHA may server as a potential nutrient antagonist to NLRC4 and our findings offer new insights into the potential mechanisms of action of DHA in mediating the beneficial hepatoprotective effects in NASH. Here, NLRC4 is linked to metabolic dysfunction-associated steatohepatitis.